Page 6 - Harvard Bioscience News Today

Harvard Bioscience (NASDAQ:HBIO – Get Free Report) and Revvity (NYSE:RVTY – Get Free Report) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, profitability and analyst recommendations. Profitability This table compares Harvard Bioscience and […]

Archon Capital Management LLC grew its stake in Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) by 4.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,361,769 shares of the medical instruments supplier’s stock after purchasing an additional 56,244 shares during the […]

Key Insights Significantly high institutional ownership implies Harvard Bioscience's stock price is sensitive to their...

Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) was the recipient of a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 386,700 shares, an increase of 10.9% from the April 30th total of 348,800 shares. Currently, 1.0% of the company’s shares are short sold. Based […]

Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 386,700 shares, an increase of 10.9% from the April 30th total of 348,800 shares. Approximately 1.0% of the shares of the company are sold short. Based on […]

Bard Associates Inc. cut its position in shares of Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) by 1.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 293,297 shares of the medical instruments supplier’s stock after selling 5,000 shares during the period. […]

Analysts’ new coverage for Thursday, May 18th: StockNews.com initiated coverage on shares of Agilent Technologies (NYSE:A). The firm issued a buy rating on the stock. StockNews.com assumed coverage on shares of Alcoa (NYSE:AA). They issued a sell rating on the stock. StockNews.com began coverage on shares of American Airlines Group (NASDAQ:AAL). StockNews.com issued a buy […]

Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) was the recipient of a significant increase in short interest in April. As of April 30th, there was short interest totalling 348,800 shares, an increase of 28.1% from the April 15th total of 272,200 shares. Currently, 1.0% of the shares of the stock are sold short. Based on […]

Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) was the target of a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 348,800 shares, a growth of 28.1% from the April 15th total of 272,200 shares. Based on an average daily trading volume, of 154,200 shares, […]

/PRNewswire/ -- The global laboratory analytical instruments and consumables market size is estimated to increase by USD 15.99 billion from 2022 to 2027. The...